Jane Street Group, LLC Lantheus Holdings, Inc. Call Options Transaction History

Jane Street Group, LLC

7 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q2 2022 Aug 16, 2022	SELL	$55.54 - $72.65 $6.23 Million - $8.14 Million	-112,100 Closed	0 $0
Q1 2022 May 17, 2022	BUY	$24.28 - $56.64 $2.22 Million - $5.18 Million	91,500 Added 444.17%	112,100 $6.2 Million
Q4 2021 Feb 15, 2022	SELL	$22.54 - $30.44 $49,588 - $66,968	-2,200 Reduced 9.65%	20,600 $595,000
Q3 2021 Nov 16, 2021	SELL	$24.23 - $28.59 $571,828 - $674,724	-23,600 Reduced 50.86%	22,800 $586,000
Q2 2021 Aug 16, 2021	SELL	$19.51 - $27.64 $571,643 - $809,852	-29,300 Reduced 38.71%	46,400 $1.28 Million
Q1 2021 May 18, 2021	BUY	$13.77 - $21.66 $50,949 - $80,142	3,700 Added 5.14%	75,700 $1.62 Million
Q4 2020 Feb 17, 2021	BUY	$10.75 - $14.91 $774,000 - $1.07 Million	72,000 New	72,000 $971,000

495

67.2M

1.19M

829K

Ticker LNTH
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 68,741,904
Market Cap $7.43B
Description
Lantheus Holdings, Inc. develops, manufactures, and commercializes diagnostic and therapeutic products that assist clinicians in the diagnosis and treatment of heart, cancer, and other diseases worldwide. It provides DEFINITY, a microbubble ultrasound enhancing agent used in ultrasound exams of the heart; TechneLite, a technetium generator for n...

Get notified when there are updates to the investment portfolio of Jane Street Group, LLC, based on Form 13F filings with the SEC.

Stay updated on Jane Street Group, LLC with notifications on news.